Company intelligence / Profile preview

Dr. Reuter Investor Relations

Germany

Ownership: Private
Development stage: Other

Overview

Dr. Reuter Investor Relations is a specialized investor relations agency founded in 2006, focusing on European capital markets. They provide financial PR, institutional IR, roadshows, and digital IR services to clients across various industries, including biotechnology, medtech, and natural resources.

Industry: Consulting

Beyond the preview

Go deeper on Dr. Reuter Investor Relations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dr. Reuter Investor Relations.

Explore the full profile